Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Hossam El Benawi Shares Multi Site LVT Study from Mayo Clinic
Hossam El Benawi/LinkedIn
Oct 27, 2025, 13:00

Hossam El Benawi Shares Multi Site LVT Study from Mayo Clinic

Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared on LinkedIn:

”Mayo Clinic Multi Site LVT Study Part 1:

DOAC Vs VKA for LVT.”

A Mayo Clinic multi-site study of 182 patients with left ventricular thrombus (LVT) found that direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) had similar effectiveness in preventing stroke or embolism and achieving thrombus resolution.

However, VKAs were linked to a higher risk of major bleeding.

The risk of embolization was greatest within the first eight weeks, suggesting that an initial DOAC loading dose may help reduce early events.

Read the full article in RPTH/ScienceDirect.

Article: Comparison of direct oral anticoagulants and vitamin K antagonists in the treatment of left ventricular thrombi: a retrospective cohort study

Authors: Hossam El Benawi, Kirsten Lipps, Samuel Heller Jr., David A. Liedl, Raymond C. Shields, Ana I. Casanegra, Stanislav Henkin, Thom W. Rooke, Paul W. Wennberg, Waldemar E. Wysokinski, Robert D. McBane, Damon E. Houghton

Hossam El Benawi Shares Multi Site LVT Study from Mayo Clinic

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.

Ana I. Casanegra Damon E Houghton David A. Liedl DOAC Health Hematology Hemostasis Hemostasis Today Hossam El Benawi Kirsten Lipps LVT Mayo Clinic Medicine Paul W. Wennberg Raymond C. Shields Robert D. McBane rpth Samuel Heller Jr. Science Direct Stanislav Henkin Thom W. Rooke thrombosis VKA Waldemar E. Wysokinski
NewsFeed